Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
The Stack Raises Rs 21.5 Crore to Expand Supplements Portfolio and R&D

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

The Stack Raises Rs 21.5 Crore to Expand Supplements Portfolio and R&D

Analysed 14 Oct 2026·2 sources analysed·New Delhi, India·Business
The Stack Raises Rs 21.5 Crore to Expand Supplements Portfolio and R&DPreviousNext

The Stack, a Bengaluru-based direct-to-consumer supplements brand founded in 2024 by Shreya Jain and Kshitij Rihal, has raised Rs 21.5 crore in a funding round co-led by Sauce.vc, OTP Ventures, and Huddle Ventures, with participation from AYRA Ventures. The company plans to use the capital to expand its team, invest in research and development, and broaden its product portfolio, which currently includes five supplements targeting sleep, gut, and functional health. The Stack aims for 6-7 times growth by FY27 and focuses on transparent, clinically studied formulations amid growing demand in India's dietary supplements market.

Sentiment
62%
TBN's observations

First-hand measurement across 2 sources

We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (62/100). Lens Score 42/100.

Outlets measured: news18, inc42media. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 14 Oct 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Positive (62/100)

Sentiment was consistent across outlets (50–75/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

inc42media broke this story on 14 Oct, 11:19 am. Other outlets followed.

14 Oct, 11:19 am2 sources · 74 min14 Oct, 12:33 pm
  1. 1
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
EPFO Revises Partial Withdrawal Rules Allowing Up to 75% EPF Access After 12 Months
Next →
Multiple BSE Stocks Reach 52-Week Highs Amid Mixed Market Trends
inc42media14 Oct, 11:19 am
The Stack Raises 21.5 Cr To Broaden Its Supplements Portfolio
  • 2
    news1814 Oct, 12:33 pm
    Supplements brand Stack raises Rs 21.5 cr from OTP Ventures, others
  • Who's involved

    Institutions and figures named across source coverage.

    Corporate
    Unilever VenturesAYRA VenturesStackSauce Venture CapitalZeropearl Venture CapitalHuddle VenturesSauceOrbiMedOTP Ventures

    Story context

    Category
    Business
    Location
    New Delhi, India
    Sources analysed
    2
    Last analysed
    14 Oct 2026
    Key entities
    Indian rupeeJainismResearch and developmentCroreNew DelhiBasketball Africa LeaguePress Trust of IndiaChromiumStartup companyIndiaGlycineGastrointestinal tract